Clinical Trial Update: Cooperative Study of Factor VIII Inhibitors [Phase 3]

View source ↗

Summary

A Phase 3 cooperative trial investigating Factor VIII inhibitors in Hemophilia A has completed enrollment; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Coagulation Disorders, Hematologic Diseases | Phase 3 | Status: COMPLETED